Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Workday
WDAY
$39B
| $41.8M | 0.01% |
543,585
+30,799
| +6% | +$2.04M |
|
|
ITC
1202
DELISTED
ITC HOLDINGS CORP
ITC
| $41.7M | 0.01% |
956,634
-239,431
| -20% | -$9.73M |
|
|
TTOO
1203
DELISTED
T2 Biosystems, Inc
TTOO
| $41.6M | 0.01% |
845
+10
| +1% | +$442K |
|
1204
Teradyne
TER
$57.2B
| $41.6M | 0.01% |
1,925,736
+782,917
| +69% | +$15.3M |
|
1205
CONMED
CNMD
$1.41B
| $41.5M | 0.01% |
990,609
+504,423
| +104% | +$19.8M |
|
1206
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $41.5M | 0.01% |
514,955
+211,446
| +70% | +$16.9M |
|
1207
Charles River Laboratories
CRL
$11.3B
| $41.4M | 0.01% |
545,510
+169,376
| +45% | +$12.5M |
|
|
CLC
1208
DELISTED
Clarcor
CLC
| $41.4M | 0.01% |
716,476
-111,996
| -14% | -$5.52M |
|
|
ESRX
1209
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $41.3M | 0.01% |
601,900
+76,700
| +15% | +$5.51M |
|
1210
PUT
Herbalife
HLF
$1.29B
| $41.3M | 0.01% |
1,342,000
-441,200
| -25% | -$11.4M |
|
|
FMER
1211
DELISTED
FIRSTMERIT CORP
FMER
| $41.2M | 0.01% |
1,958,611
+1,638,288
| +511% | +$31.7M |
|
1212
CALL
EOG Resources
EOG
$77.5B
| $41.2M | 0.01% |
567,400
-158,100
| -22% | -$10.9M |
|
1213
CALL
Public Storage
PSA
$59.3B
| $41.1M | 0.01% |
148,900
-65,500
| -31% | -$16.5M |
|
1214
TotalEnergies
TTE
$193B
| $41M | 0.01% |
903,110
-257,299
| -22% | -$11.3M |
|
1215
Toyota
TM
$227B
| $41M | 0.01% |
385,617
-29,986
| -7% | -$3.31M |
|
1216
Constellation Brands
STZ
$22.3B
| $40.9M | 0.01% |
270,585
-542,850
| -67% | -$78.4M |
|
1217
Casey's General Stores
CASY
$32.1B
| $40.9M | 0.01% |
360,518
+196,076
| +119% | +$22M |
|
|
CELG
1218
CALL
DELISTED
Celgene Corp
CELG
| $40.8M | 0.01% |
407,900
-142,600
| -26% | -$14.7M |
|
1219
PUT
Honeywell
HON
$76.7B
| $40.7M | 0.01% |
404,315
+105,058
| +35% | +$9.85M |
|
1220
PUT
Philip Morris
PM
$299B
| $40.7M | 0.01% |
414,600
+153,800
| +59% | +$14.1M |
|
1221
Toll Brothers
TOL
$14B
| $40.6M | 0.01% |
1,375,365
+272,058
| +25% | +$7.6M |
|
1222
AutoNation
AN
$7.18B
| $40.5M | 0.01% |
867,617
-292,415
| -25% | -$14.2M |
|
1223
PUT
UBS Group
UBS
$175B
| $40.4M | 0.01% |
2,521,032
+2,114,500
| +520% | +$34.3M |
|
1224
PUT
UnitedHealth
UNH
$383B
| $40.4M | 0.01% |
313,300
-108,300
| -26% | -$12.8M |
|
1225
Ciena
CIEN
$52.7B
| $40.3M | 0.01% |
2,121,402
+811,455
| +62% | +$15M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.